Pharmaceutical Packaging Market Size, Share & Trends Analysis Report By Material (Plastics & Polymers, Paper & Paperboard, Glass, Aluminum Foil), By Product (Primary, Secondary And Tertiary), By End-Use (Pharma Manufacturing, Contract Packaging, Retail Pharmacy And Institutional Pharmacy), By Drug Delivery, By Region, And Segment Forecasts, 2025-2034

Report Id: 1747 Pages: 180 Last Updated: 23 September 2025 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Segmentation of Pharmaceutical Packaging Market-

Pharmaceutical Packaging Market By Material

  • Plastics & Polymers
    • Polyvinyl Chloride (PVC)
    • Polypropylene (PP)
      • Homo
      • Random
    • Polyethylene Terephthalate (PET)
    • Polyethylene (PE)
      • HDPE
      • LDPE
      • LLDPE
    • Polystyrene (PS)
    • Others
  • Paper & Paperboard
  • Glass
  • Aluminium Foil
  • Others 

pharma packaging

Pharmaceutical Packaging Market By Product

  • Primary
    • Plastic Bottles
    • Caps & Closures
    • Parenteral Containers
      • Syringes
      • Vials & Ampoules
      • Others
    • Blister Packs
    • Prefillable Inhalers
    • Pouches
    • Medication Tubes
    • Others
  • Secondary
    • Prescription Containers
    • Pharmaceutical Packaging Accessories
  • Tertiary

Pharmaceutical Packaging Market By Drug Delivery

  • Oral
  • Pulmonary
  • Transdermal
  • Injectable
  • Topical
  • Nasal
  • Ocular/Ophthalmic
  • Intravenous
  • Other Drug Delivery Modes

Pharmaceutical Packaging Market By End-use

  • Pharma Manufacturing
  • Contract Packaging
  • Retail Pharmacy
  • Institutional Pharmacy

Pharmaceutical Packaging Market By Region-

North America-

  • The US
  • Canada

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

Chapter 1.    Methodology and Scope

1.1.    Research Methodology
1.2.    Research Scope & Assumptions

Chapter 2.    Executive Summary

Chapter 3.    Global Pharmaceutical Contract Packaging Market Snapshot

Chapter 4.    Global Pharmaceutical Contract Packaging Market Variables, Trends & Scope

4.1.    Market Segmentation & Scope
4.2.    Drivers
4.3.    Challenges
4.4.    Trends 
4.5.    Investment and Funding Analysis 
4.6.    Porter's Five Forces Analysis
4.7.    Incremental Opportunity Analysis (US$ MN), 2024-2034 
4.8.    Global Pharmaceutical Contract Packaging Market Penetration & Growth Prospect Mapping (US$ Mn), 2023-2031
4.9.    Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.10.    Use/impact of AI on Pharmaceutical Contract Packaging Market Industry Trends 

Chapter 5.    Pharmaceutical Contract Packaging Market Segmentation 1: By Material, Estimates & Trend Analysis

5.1.    Market Share by Material, 2023 & 2034
5.2.    Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Material:

5.2.1.    Plastic
5.2.2.    Glass
5.2.3.    Aluminum Foil
5.2.4.    Paper & Paperboard
5.2.5.    Others

Chapter 6.    Pharmaceutical Contract Packaging Market Segmentation 2: By Type, Estimates & Trend Analysis

6.1.    Market Share by Type, 2023 & 2034
6.2.    Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Type:

6.2.1.    Primary Packaging
6.2.2.    Secondary Packaging

Chapter 7.    Pharmaceutical Contract Packaging Market Segmentation 3: By End User, Estimates & Trend Analysis

7.1.    Market Share by End User, 2023 & 2034
7.2.    Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following End User:

7.2.1.    Pharmaceutical Manufacturing Companies
7.2.2.    Biopharmaceutical Companies
7.2.3.    Contract Research Organizations
7.2.4.    Others

Chapter 8.    Pharmaceutical Contract Packaging Market Segmentation 4: Regional Estimates & Trend Analysis

8.1.    Global Pharmaceutical Contract Packaging Market, Regional Snapshot 2023 & 2034

8.2.    North America

8.2.1.    North America Pharmaceutical Contract Packaging Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034

8.2.1.1.    US
8.2.1.2.    Canada

8.2.2.    North America Pharmaceutical Contract Packaging Market Revenue (US$ Million) Estimates and Forecasts by Material, 2021-2034
8.2.3.    North America Pharmaceutical Contract Packaging Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
8.2.4.    North America Pharmaceutical Contract Packaging Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034

8.3.    Europe

8.3.1.    Europe Pharmaceutical Contract Packaging Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034

8.3.1.1.    Germany
8.3.1.2.    U.K.
8.3.1.3.    France
8.3.1.4.    Italy
8.3.1.5.    Spain
8.3.1.6.    Rest of Europe

8.3.2.    Europe Pharmaceutical Contract Packaging Market Revenue (US$ Million) Estimates and Forecasts by Material, 2021-2034
8.3.3.    Europe Pharmaceutical Contract Packaging Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
8.3.4.    Europe Pharmaceutical Contract Packaging Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034

8.4.    Asia Pacific

8.4.1.    Asia Pacific Pharmaceutical Contract Packaging Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034

8.4.1.1.    India 
8.4.1.2.    China
8.4.1.3.    Japan
8.4.1.4.    Australia
8.4.1.5.    South Korea
8.4.1.6.    Hong Kong
8.4.1.7.    Southeast Asia
8.4.1.8.    Rest of Asia Pacific

8.4.2.    Asia Pacific Pharmaceutical Contract Packaging Market Revenue (US$ Million) Estimates and Forecasts by Material, 2021-2034
8.4.3.    Asia Pacific Pharmaceutical Contract Packaging Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
8.4.4.    Asia Pacific Pharmaceutical Contract Packaging Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034

8.5.    Latin America

8.5.1.    Latin America Pharmaceutical Contract Packaging Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034

8.5.1.1.    Brazil
8.5.1.2.    Mexico
8.5.1.3.    Rest of Latin America

8.5.2.    Latin America Pharmaceutical Contract Packaging Market Revenue (US$ Million) Estimates and Forecasts by Material, 2021-2034
8.5.3.    Latin America Pharmaceutical Contract Packaging Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
8.5.4.    Latin America Pharmaceutical Contract Packaging Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034

8.6.    Middle East & Africa

8.6.1.    Middle East & Africa Pharmaceutical Contract Packaging Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034

8.6.1.1.    GCC Countries
8.6.1.2.    Israel
8.6.1.3.    South Africa
8.6.1.4.    Rest of Middle East and Africa

8.6.2.    Middle East & Africa Pharmaceutical Contract Packaging Market Revenue (US$ Million) Estimates and Forecasts by Material, 2021-2034
8.6.3.    Middle East & Africa Pharmaceutical Contract Packaging Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
8.6.4.    Middle East & Africa Pharmaceutical Contract Packaging Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034

Chapter 9.    Competitive Landscape

9.1.    Major Mergers and Acquisitions/Strategic Alliances
9.2.    Company Profiles

9.2.1.    Catalent, Inc.
9.2.1.1.    Business Overview
9.2.1.2.    Key Product/Service Overview
9.2.1.3.    Financial Performance
9.2.1.4.    Geographical Presence
9.2.1.5.    Recent Developments with Business Strategy
9.2.2.    AbbVie Contract Manufacturing
9.2.3.    Patheon (Thermo Fisher Scientific)
9.2.4.    Baxter BioPharma Solutions
9.2.5.    Nipro Corporation
9.2.6.    Pfizer CentreOne
9.2.7.    Recipharm AB
9.2.8.    Vetter Pharma International GmbH
9.2.9.    NextPharma Technologies
9.2.10.    Sharp
9.2.11.    Others 

Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
1767
Security Code field cannot be blank!

Frequently Asked Questions

Pharmaceutical Packaging Market Size is valued at USD 134.3 Billion in 2024 and is predicted to reach USD 356.7 Billion by the year 2034

Pharmaceutical Packaging Market expected to grow at a 10.4% CAGR during the forecast period for 2025-2034

Amcor plc; Becton, Dickinson, and Company; AptarGroup, Inc.; Drug Plastics Group; Hergesheimer AG; Schott AG; Owens Illinois, Inc.; West Pharmaceutica

Pharmaceutical packaging market is segmented on material, product, drug delivery and end user.

North American region is leading the Pharmaceutical packaging market.

Report License Selection

Determine the Appropriate License for your Report

Get Sample Report Enquiry Before Buying